期刊文献+

抗青光眼药物使用分析 被引量:3

Analysis of the antiglaucoma agents
下载PDF
导出
摘要 目的:评价本院2004—2006年抗青光眼用药的应用状况及发展趋势。方法:对本院2004—2006年抗青光眼用药的销售金额进行统计和分析。结果:3年中本院抗青光眼药的金额呈逐年上升趋势;滴眼剂销售额中以β-受体阻断剂和拟胆碱药排名在前两位,口服药以视神经保护剂和高渗剂为主。结论:本院抗青光眼用药的应用状况与抗青光眼用药原则基本相符。 OBJECTIVE To analyze the current situation and developing trend used in our hospital during the period 2004- 2006. METHODS To make a survey of antiglaucoma drugs in respect to the total consumption . RESULTS The trend of total consumption increased in the past three years. Among the eye drops, β - receptor antagonists and cholinomimetic drugs occupied the front two places in sequence of the total consumption. Optic nerve protecting drugs and diuretic drugs were the most commonly - used oral drugs. CONCLUSION The use of antiglaucoma drugs in our hospital match the principle for using antiglaucoma drugs.
作者 陆海
机构地区 天津市眼科医院
出处 《天津药学》 2007年第6期38-40,共3页 Tianjin Pharmacy
关键词 青光眼 抗青光眼药品 销售金额 用药分析 Glaucoma,antiglaucoma agent,The money of consumption,analysis
  • 相关文献

参考文献6

二级参考文献34

共引文献175

同被引文献18

  • 1余敏斌,李劲嵘.青光眼药物治疗的新概念[J].中华眼科杂志,2006,42(3):283-288. 被引量:52
  • 2陈晓明,刘旭阳.抗青光眼药物联合治疗的策略[J].中华眼科杂志,2006,42(11):1047-1050. 被引量:9
  • 3邱敬华,刘旭阳,武正清.青光眼药物治疗的回顾和展望[J].国际眼科杂志,2007,7(3):754-758. 被引量:20
  • 4Aim A,Schoenfelder J,McDermott J.A5-year,multicenter,open-label,safety study of adjunctive latanopmst therapy for glaucoma[J].Arch Ophthalmol.2004,122:957-965. 被引量:1
  • 5Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma[J].Surv Ophthalmol, 2002,47 (suppl 1 ):225. 被引量:1
  • 6Chiselita D. Evaluation of open of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients [J].Optalmologia, 2007,51(2):81-86. 被引量:1
  • 7Aim A,Schoenfelder J, McDermott J.A5 -year, muhicenter, openlabel,safety study of adjunctive latanopmst therapy for glau- coma[J].Arch Ophthalmol, 2004,122:957-965. 被引量:1
  • 8Soltau J B,Zimmerman T J. Changing paradigms in the medical treatment of glaucoma[J].{H}Survey of Ophthalmology,2002,(01):225. 被引量:1
  • 9Chiselita D. Evaluation of open of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients[J].Optalmologia,2007,(02):81. 被引量:1
  • 10Aim A,Schoenfelder J,McDermott J. A 5-year,multicenter,openlabel,safety study of adjunctive latanoprost therapy for glaucoma[J].{H}Archives of Ophthalmology,2004.957. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部